Chemical fragments as foundations for understanding target space and activity prediction

被引:50
作者
Sutherland, Jeffrey J. [1 ]
Higgs, Richard E. [2 ]
Watson, Ian [3 ]
Vieth, Michal [3 ]
机构
[1] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Discovery Informat, Indianapolis, IN 46285 USA
[2] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Discovery Stat, Indianapolis, IN 46285 USA
[3] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Discovery Chem, Indianapolis, IN 46285 USA
关键词
D O I
10.1021/jm701399f
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The use of small inhibitors' fragment frequencies for understanding kinase potency and selectivity is described. By quantification of differences in the frequency of occurrence of fragments, similarities between small molecules and their targets can be determined. Naive Bayes models employing fragments provide highly interpretable and reliable means for predicting potency in individual kinases, as demonstrated in retrospective tests and prospective selections that were subsequently screened. Statistical corrections for prospective validation allowed us to accurately estimate success rates in the prospective experiment. Selectivity relationships between kinase targets are substantially explained by differences in the fragment composition of actives. By application of fragment similarities to the broader proteome, it is shown that targets related by sequence exhibit similar fragment preferences in small molecules. Of greater interest, certain targets unrelated by sequence are shown to have similar fragment preferences, even when the chemical similarity of ligands active at each target is low.
引用
收藏
页码:2689 / 2700
页数:12
相关论文
共 34 条
[1]   A common reference framework for analyzing/comparing proteins and ligands. Fingerprints for ligands and proteins (FLAP): Theory and application [J].
Baroni, Massimo ;
Cruciani, Gabriele ;
Sciabola, Simone ;
Perruccio, Francesca ;
Mason, Jonathan S. .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2007, 47 (02) :279-294
[2]   The properties of known drugs .1. Molecular frameworks [J].
Bemis, GW ;
Murcko, MA .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (15) :2887-2893
[3]   Properties of known drugs. 2. Side chains [J].
Bemis, GW ;
Murcko, MA .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (25) :5095-5099
[4]   Bayes affinity fingerprints improve retrieval rates in virtual screening and define orthogonal bioactivity space: When are multitarget drugs a feasible concept? [J].
Bender, Andreas ;
Jenkins, Jeremy L. ;
Glick, Meir ;
Deng, Zhan ;
Nettles, James H. ;
Davies, John W. .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2006, 46 (06) :2445-2456
[5]   A combinatorial approach toward the discovery of non-peptide, subtype-selective somatostatin receptor ligands [J].
Berk, SC ;
Rohrer, SP ;
Degrado, SJ ;
Birzin, ET ;
Mosley, RT ;
Hutchins, SM ;
Pasternak, A ;
Schaeffer, JM ;
Underwood, DJ ;
Chapman, KT .
JOURNAL OF COMBINATORIAL CHEMISTRY, 1999, 1 (05) :388-396
[6]   ATOM PAIRS AS MOLECULAR-FEATURES IN STRUCTURE ACTIVITY STUDIES - DEFINITION AND APPLICATIONS [J].
CARHART, RE ;
SMITH, DH ;
VENKATARAGHAVAN, R .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 1985, 25 (02) :64-73
[7]   Molecular basis for specificity in the druggable kinome: sequence-based analysis [J].
Chen, Jianping ;
Zhang, Xi ;
Fernandez, Ariel .
BIOINFORMATICS, 2007, 23 (05) :563-572
[8]   Fragment-based lead discovery: a chemical update [J].
Erlanson, Daniel A. .
CURRENT OPINION IN BIOTECHNOLOGY, 2006, 17 (06) :643-652
[9]   METHODS FOR DRUG DISCOVERY - DEVELOPMENT OF POTENT, SELECTIVE, ORALLY EFFECTIVE CHOLECYSTOKININ ANTAGONISTS [J].
EVANS, BE ;
RITTLE, KE ;
BOCK, MG ;
DIPARDO, RM ;
FREIDINGER, RM ;
WHITTER, WL ;
LUNDELL, GF ;
VEBER, DF ;
ANDERSON, PS ;
CHANG, RSL ;
LOTTI, VJ ;
CERINO, DJ ;
CHEN, TB ;
KLING, PJ ;
KUNKEL, KA ;
SPRINGER, JP ;
HIRSHFIELD, J .
JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (12) :2235-2246
[10]   A small molecule-kinase interaction map for clinical kinase inhibitors [J].
Fabian, MA ;
Biggs, WH ;
Treiber, DK ;
Atteridge, CE ;
Azimioara, MD ;
Benedetti, MG ;
Carter, TA ;
Ciceri, P ;
Edeen, PT ;
Floyd, M ;
Ford, JM ;
Galvin, M ;
Gerlach, JL ;
Grotzfeld, RM ;
Herrgard, S ;
Insko, DE ;
Insko, MA ;
Lai, AG ;
Lélias, JM ;
Mehta, SA ;
Milanov, ZV ;
Velasco, AM ;
Wodicka, LM ;
Patel, HK ;
Zarrinkar, PP ;
Lockhart, DJ .
NATURE BIOTECHNOLOGY, 2005, 23 (03) :329-336